Pharmaceutical Filtration Market | Market Research Report Updates

The global ophthalmic lasers market is anticipated to reach USD 1.6 billion by 2025, according to a new report by Grand View Research, Inc. Ophthalmic disorders are rising significantly on a global level. This rise in the prevalence rate has led to high growth of ophthalmic lasers market.

According to American Academy of Ophthalmology 2014 statistics, nearly 4.2 million people in the U.S. are visually impaired. Huge number of people suffering from visual impairment are likely to heighten the demand for ophthalmic lasers in the coming years.

Vision loss is a serious problem among people suffering from glaucoma, cataract, age-related macular degeneration (AMD), and diabetic retinopathy. This commonly occurs among the geriatric population. American Academy of Ophthalmology stated that, around 1.3 million U.S. population are blind. Hence, in order to minimize such huge rate of vision loss, there is a high need for the application of ophthalmic laser technology.

Geriatric population are the primary target for the market. Majority of the chronic ophthalmic disorders, for instance, cataract and AMD occur among this group of population. However, refractive errors are also very common among the young people. Thus, growing number of victims of chronic eye diseases has led to an expected growth of the market.

Browse full research report on Global Ophthalmic Lasers Market: http://www.grandviewresearch.com/industry-analysis/ophthalmic-lasers-market

Further key findings from the study suggest:

In 2016, femtosecond lasers dominated the market due to rising prevalence of refractive errors among both geriatric and young population
Amongst the application segment, refractive error corrections held the largest market share in 2016 due to large number of surgeries conducted for refractive errors
Cataract removal is anticipated to show lucrative growth over the forecast period owing to the rising prevalence of cataract removal surgeries among the geriatric people
In 2016, hospitals contributed towards the largest revenue share owing to the emergence of large number of hospitals in developing economies
North America dominated the market in 2016 due to rising prevalence of ophthalmic disorders in this region
Asia Pacific is expected to show lucrative growth over the forecast period owing to the increase in awareness levels among people in developing countries about various treatments for chronic eye disorders
Few major companies include Carl Zeiss Meditec AG, Abbott Medical Optics, Inc., Alcon Laboratories, Inc., Ellex Medical Lasers Limited, Lumenis, and Bausch & Lomb Incorporated.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the ophthalmic lasers market on the basis of product, application, end-use, and region:

Ophthalmic Lasers Product Outlook (Revenue, USD Million, 2014 – 2025)

Diode Lasers
Femtosecond Lasers
Excimer Lasers
Nd:YAG lasers
SLT Lasers
Others

Ophthalmic Lasers Application Outlook (Revenue, USD Million, 2014 – 2025)

Glaucoma
Cataract Removal
Refractive Error Corrections
Diabetic Retinopathy
AMD
Others

Ophthalmic Lasers End-use Outlook (Revenue, USD Million, 2014 – 2025)

Hospitals
Ambulatory Surgical Centers
Ophthalmic Clinics

Ophthalmic Lasers Regional Outlook (Revenue, USD Million, 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- UK
Asia Pacific
- Japan
- China
- India
Latin America
- Brazil
- Mexico
MEA
- South Africa

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com

The global pharmaceutical filtration market is expected to reach USD 37.3 billion by the year 2025 growing at a CAGR of 12.1%, according to a new report by Grand View Research, Inc. The growing expansion of the biopharmaceutical industry have resulted in enormous growth of the market with new and more enhanced technologies being used to cater to the need of drug manufacturers. Increasing demand for therapeutic biopharmaceuticals such as antibodies,hormones, and vaccines is a major factor that drives growth of the market during forecast period. Thus, many pharmaceuticals and biotechnology companies have begun to focus on the development of advanced biologics for the treatment of severe chronic diseases including cancer, heart disease, and rheumatic arthritis.

Increasing investment in the R&D by pharmaceutical and biotechnology companies is another major factor supporting the growth of the sector. Technological advancements in filtration products is also expected to propel their adoption in manufacturing and research of biopharmaceuticals and other drugs. The technological advanced filters including membrane, pre-filters & depth media, and cartridges & capsules filters provide high reliability and efficiency during drug manufacturing process.

Browse full research report on Global Pharmaceutical Filtration Market: http://www.grandviewresearch.com/industry-analysis/pharmaceutical-filtration-market

Further Key Findings From The Report Suggest:

Microfiltration is the fastest growing technique amongst others owing to its large application in generic and biopharmaceutical drug productions
Final product processing was the largest revenue-grossing as well as fastest growing segment of the pharmaceutical filtration market, due to increase in number of companies engaged in pharmaceuticals and biologics production
Membrane filters held the largest revenue share in the overall sector, which is attributed by its high usage in production, research, environmental testing, and other applications in the pharmaceutical industry
MCE membrane filters accounted for the largest share in the membrane filters segment, due to its product advancement
The manufacturing scale dominated the market in terms of revenue in 2016 owing to the increasing production of generic drugs and biopharmaceutical products
North America is the leading regional sector, which is accounted for the largest revenue share of the overall market in 2016, because of the presence of large number of pharmaceutical, biopharmaceutical, and biotechnology companies in this region
The Asia Pacific region is expected to grow at a highest CAGR during the forecast period due to escalating presence of drug manufacturers in the developing countries such as China and India
Some of the major players include Eaton Corporation Plc; GE Healthcare, Parker Hannifin Corporation; Merck KGaA; Danaher Corporation, 3M; Amazon Filters Ltd.; Sartorius Stedim Biotech S.A.; Graver Technologies, LLC; and Meissner Filtration Products, Inc.

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Grand View Research has segmented the global pharmaceutical filtration on the basis of product, technique, application, scale of operation, and region:

Product Outlook (Revenue, USD Million; 2014 – 2025)

Membrane filters
- MCE membrane filters
- Coated cellulose acetate membrane filters
- PTFE membrane filters
- Nylon membrane filters
- PVDF membrane filters
- Other membrane filters
Prefilters & depth media
- Glass fiber filters
- PTFE fiber filters
- Single-use systems
- Cartridges & capsules
- Filter holders
- Filtration accessories
- Others

Technique Outlook (Revenue, USD Million; 2014 – 2025)

Microfiltration
Ultrafiltration
Cross flow filtration
Nanofiltration
Others

Application Outlook (Revenue, USD Million; 2014 – 2025)

Final product processing
- Active pharmaceutical ingredient filtration
- Sterile filtration
- Protein purification
- Vaccines and antibody processing
- Formulation and filling solutions
- Viral clearance
Raw material filtration
- Media buffer
- Pre-filtration
- Bioburden testing
Cell separation
Water purification
Air purification

Scale of Operation Outlook (Revenue, USD Million; 2014 – 2025)

Manufacturing scale
Pilot scale
Research & development scale

Regional Outlook (Revenue, USD Million; 2014 – 2025)

North America
- U.S.
- Canada
Europe
- Germany
- UK
Asia Pacific
- Japan
- China
- India
Latin America
- Brazil
- Mexico
MEA
- South Africa

About Grand View Research

For more information: www.grandviewresearch.com